James L. Tyree

James L. Tyree (board member) discloses dealings in 3 companies, chiefly Genelux Corp, Assertio Holdings, Inc. and ChemoCentryx, Inc. In total, 21 filings cover trades dated from 11 May 2021 to 16 June 2026.

Both buying and selling appear: 1 purchase, against 8 sales worth €1.0M. The totals do not cover 1 filing with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 8 share grants and 3 option exercises.

The latest filing, published on 18 June 2026, reports a share grant in Genelux Corp. The clock since the last published purchase (7 June 2024) now reads 863 days. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.